Navigation Links
Insulet Announces Sponsorship of International Diabetes Federation's World Diabetes Day Campaign

BEDFORD, Mass., Nov. 3 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the global leader in patch pump technology, and the International Diabetes Federation (IDF) today announced that Insulet is an official partner of IDF's World Diabetes Day (WDD) campaign. World Diabetes Day, celebrated on November 14, will raise awareness of children and adolescents with diabetes, spotlighting both the impact of the disease and access to care.

"Insulet's mission is to improve the lives of people with diabetes, so we felt it was imperative to join IDF to increase global awareness of this devastating disease, which affects millions of people worldwide," said Duane DeSisto, Insulet's president & chief executive officer. "Our easy-to-use OmniPod(R) Insulin Management System helps people with diabetes stay healthy while living life fully. OmniPod's innovative, tubing-free design provides all the benefits of pump therapy, which supplies the best control over diabetes, while eliminating the hassles of a traditional pump. Its virtually pain-free automated insertion has no needles in sight, which appeals to both children and adults. But primarily, OmniPod enables people with diabetes to simply live their lives normally."

The campaign also emphasizes that, with the right treatment, children and adolescents can live full, healthy and productive lives. To ensure this, it's vital that parents know the early warning signs of diabetes and if their child shows these signs, to seek immediate medical attention. These signs include:

-- Frequent urination

-- Excessive thirst

-- Increased hunger

-- Rapid weight loss

-- Tiredness

-- Lack of interest and concentration

-- Blurred vision

-- Vomiting and stomach pain (often mistaken as the flu)

"We are extremely pleased that Insulet is an official partner in World Diabetes Day and very much welcome their support and expertise in diabetes to bring attention to the disease," said World Diabetes Day Campaign Director Phil Riley.

Introduced by IDF and the World Health Organization in 1991, World Diabetes Day is celebrated every year on November 14 because it marks the birthday of Frederick Banting, who, along with Charles Best, is credited with the discovery of insulin. All WDD partners share the goal of increasing diabetes awareness, care and priority in the world health arena.

In addition to partnering in the WDD campaign, Insulet is focused on raising awareness of diabetes during November, National Diabetes Awareness Month, through a series of local market efforts in cities throughout the United States.

About Type 1 Diabetes

Type 1 diabetes is an autoimmune disease characterized by the destruction of more than 90% of the body's insulin-producing cells. It can neither be prevented nor cured. Globally, it is the most common form of diabetes in children, affecting around 500,000 children under 15, with 70,000 new cases diagnosed each year. Prevalence is increasing most quickly among pre-school children, at a rate of 5% per year.

About the International Diabetes Federation

The International Diabetes Federation (IDF) is an umbrella organization of over 200 member associations in more than 160 countries, advocating for the more than 250 million people with diabetes, their families, and their healthcare providers. Its mission is to promote diabetes care, prevention and a cure worldwide. The International Diabetes Federation is an NGO in official relations with the World Health Organization and an associated NGO with the United Nations Department of Public Information. The International Diabetes Federation leads the World Diabetes Day and Unite for Diabetes campaigns. Additional information is available at

About the OmniPod Insulin Management System

Cleared by the Food & Drug Administration (FDA) in January 2005, the OmniPod Insulin Management System offers people living with insulin-requiring diabetes unprecedented freedom, comfort and ease in managing their diabetes. The System currently consists of two devices, the compact, lightweight OmniPod, which is worn discreetly beneath clothing and delivers precise, personalized doses of insulin based on instructions programmed wirelessly using its companion, the handheld, wireless Personal Diabetes Manager (PDM). The OmniPod features no tubing and virtually pain-free automated insertion. The PDM, which is very similar in look and feel to a personal digital assistant, features an integrated blood glucose meter, disease management software and integrated storage and display of all insulin delivery, blood glucose and carbohydrate records.

About Insulet Corporation

Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully-automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-requiring diabetes. Founded in 2000, Insulet is based in Bedford, MA.


Rachel Kessler, Lazar Partners

(917) 660-0608

Mark Sahl, Lazar Partners

(646) 871-8485

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. Insulet Corporation Announces Pricing of Secondary Public Offering
3. Insulet Corporation to Report Third Quarter 2007 Financial Results on Wednesday, November 14th
4. Insulet Corporation to Present at the JPMorgan Healthcare Conference on January 8, 2008
5. Insulet Corporation and DexCom Announce Development Agreement
6. Insulet Corporation to Present at the Seventh Annual JMP Securities Research Conference on May 20, 2008
7. Insulet Corporation to Present at the Canaccord Adams Diabetes & Obesity Conference on June 6, 2008
8. Insulet Announces Development Agreement for the First Non-Diabetes Drug Delivery Application for the OmniPod System
9. Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
10. Insulet Corporation Announces Pricing of $75 Million of Convertible Senior Notes
11. Insulet Corporation to Present at the William Blair & Company 28th Annual Growth Stock Conference on June 19, 2008
Post Your Comments:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... ... 2015 , ... The rapid speed at which Americans are ... care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more ... forgotten part of this equation: 80 percent of medical care occurs in the ...
(Date:11/27/2015)... County, CA (PRWEB) , ... November 27, 2015 , ... ... season , The company is offering customers 10% off of their purchase of lice ... any treatment at full price. According to a company spokesperson. “Finding lice is a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Consistent ... sharing, the 2016 Building Better Radiology Marketing Programs meeting will showcase ... Sunday, March 6, 2016, at Caesars Palace in Las Vegas with a pre-conference ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
Breaking Medicine Technology: